Laîche à bec court

Carex brevicollis

Carex brevicollis, a plant native to certain regions, has not been traditionally used in any known medical practices. Scientific research on its medicinal properties is limited; however, a study achieved a total synthesis of brevicarine from the plant, while attempts at synthesizing brevicolline resulted in unexpected derivatives. This suggests possible connections between Carex brevicollis and Erythronium dens-canis with recurrent outbreaks of myelodysplasia in newborn calves, though this link is not fully understood. The concentrations of brevicarine and brevicolline vary by plant part and altitude but do not show a clear response to growing degree days. Biscogniauxia nummularia can exist both saprotrophically and endophytically in beech trees and sedge Carex brevicollis, indicating potential ecological interactions. No major safety issues or recorded drug interactions have been noted for this plant.

En bref
Meilleure preuve
D
Précautions

Information uniquement. L'usage traditionnel ne signifie pas une efficacité prouvée. Les preuves et la sécurité varient — consultez les sources citées.

Ce que dit la science

  • Une nouvelle synthèse totale de la brevicarine a été réalisée, tandis que les essais de synthèse de la brevicolline ont abouti à des dérivés inattendus. D PMID
  • Les concentrations de brevicarine et de brevicolline dans Carex brevicollis variaient selon les parties du plant et l'altitude mais ne montraient aucune réponse claire aux degrés-jours de croissance. D PMID
  • L'étude suggère que Carex brevicollis pourrait être associé à des éruptions récurrentes de la myélodysplasie chez les veaux nouveau-nés. D PMID
  • Biscogniauxia nummularia peut exister de manière saprophyte ou endophyte dans les chênes et la joncaille Carex brevicollis. D EPMC

Frequently asked questions

What is Laîche à bec court?

Laîche à bec court (Carex brevicollis) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.

What does the scientific evidence say about Laîche à bec court?

4 sourced findings are recorded for Laîche à bec court; the strongest carries evidence grade D. For example: Une nouvelle synthèse totale de la brevicarine a été réalisée, tandis que les essais de synthèse de la brevicolline ont abouti à des dérivés inattendus.

How strong is the evidence for Laîche à bec court?

The strongest finding for Laîche à bec court carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).

Is Laîche à bec court safe? What are the side effects?

No major safety issues are recorded for Laîche à bec court in our sources, but the data may be incomplete. Consult a qualified professional before use.

Does Laîche à bec court interact with medications?

No drug interactions are recorded for Laîche à bec court in our sources. This does not rule them out — check with a pharmacist.

What are the common names of Laîche à bec court?

Laîche à bec court is also known as: Осока парвская.

Is Laîche à bec court a proven treatment?

No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.

Sources

  1. T2 Biscogniauxia nummularia infecting beech (Fagus sylvatica) trees and sympatric plants of the sedge Carex brevicollis literature abstract metadata
  2. T2 Phenological changes in the concentration of alkaloids of Carex brevicollis in an Alpine rangeland. literature abstract metadata
  3. T2 Recurrent outbreaks of myelodysplasia in newborn calves. literature abstract metadata
  4. T2 Studies on the syntheses of β-carboline alkaloids brevicarine and brevicolline. literature abstract metadata